About moroctocog alfa + vial
Recombinant factor VIII clotting factor
Used for
- Treats and prevents bleeding in haemophilia A.
- Used to control bleeding during surgery in haemophilia A.
Usual adult dose
Dose is individualised by bleed severity, target factor level, and response; commonly 20–40 IU/kg for minor bleeding.
Usual dose in children
Individualised by weight and bleeding severity; children may need more frequent doses because factor VIII clears faster.
Common side effects
- Headache
- Fever
- Nausea
- Injection-site reactions
Important warnings
- Allergic reactions, including severe reactions, can occur.
- Some people develop factor VIII inhibitors, reducing treatment effectiveness.
- Seek urgent care for symptoms of a serious allergic reaction.
- Not for von Willebrand disease or haemophilia B.
Pregnancy
Pregnancy data are limited; use when clearly needed under specialist supervision.
Breastfeeding
It is not known whether this medicine passes into breast milk; discuss use with a clinician.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.